Victor K. Johnston - Concepedia

Author

Victor K. Johnston

GlaxoSmithKline (United States)

Also Known As

Victor Johnston, Victor K Johnston, Victor K. Johnston

Publications

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)United States Military Academy South College GlaxoSmithKline (United Kingdom)Indiana University Bloomington

About

Victor K. Johnston is an author at GlaxoSmithKline (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	144
2	Biochemistry	3	3	86
3	Molecular Biology	2	2	32
4	Natural Sciences	1	1	26
5	Biomolecular Engineering	1	1	44

Victor K. Johnston

Publications

Citations

H-Index

Page 1

	Year	Citations
Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA Polymerase Dashyant Dhanak, Kevin J. Duffy, Victor K. Johnston, Journal of Biological Chemistry	2002	196
3-(1,1-Dioxo-2<i>H</i>-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1<i>H</i>)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Rosanna Tedesco, Antony N. Shaw, Ramesh Bambal, Journal of Medicinal Chemistry	2006	159
Potent, Orally Bioavailable Calcitonin Gene-Related Peptide Receptor Antagonists for the Treatment of Migraine: Discovery of <i>N</i> -[(3 <i>R</i> ,6 <i>S</i> )-6-(2,3-Difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1 <i>H</i> -imidazo[4,5- <i>b</i> ]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974) Daniel V. Paone, Anthony W. Shaw, Diem N. Nguyen, Journal of Medicinal Chemistry	2007	146
Pharmacological Characterization of MK-0974 [N-[(3 R,6 S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1 H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine Christopher Salvatore, James C. Hershey, Halea A. Corcoran, Journal of Pharmacology and Experimental Therapeutics	2007	145
Resistance Profile of a Hepatitis C Virus RNA-Dependent RNA Polymerase Benzothiadiazine Inhibitor Tammy Nguyen, Adam Gates, Lester L. Gutshall, Antimicrobial Agents and Chemotherapy	2003	89
Arresting Initiation of Hepatitis C Virus RNA Synthesis Using Heterocyclic Derivatives Baohua Gu, Victor K. Johnston, Lester L. Gutshall, Journal of Biological Chemistry	2003	68
An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: Potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase Karen A. Evans, Deping Chai, Todd L. Graybill, Bioorganic & Medicinal Chemistry Letters Asymmetric Solid-phase SynthesisBiochemistryAntiviral TherapyVirologyBenzothiadiazine-substituted Tetramic Acids	2006	44
Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase Antony N. Shaw, Rosanna Tedesco, Ramesh Bambal, Bioorganic & Medicinal Chemistry Letters MedicineAntiviral Drug DevelopmentHepatitisVirologyBenzothiadizine Inhibitors	2009	44
The discovery of highly potent CGRP receptor antagonists Craig A. Stump, Ian M. Bell, Rodney A. Bednar, Bioorganic & Medicinal Chemistry Letters G Protein-coupled ReceptorMedicineFunctional SelectivityReceptor (Biochemistry)Pharmacotherapy	2008	35
Synthesis and biological activity of heteroaryl 3-(1,1-dioxo-2H-(1,2,4)-benzothiadizin-3-yl)-4-hydroxy-2(1H)-quinolinone derivatives as hepatitis C virus NS5B polymerase inhibitors Rosanna Tedesco, Deping Chai, Michael G. Darcy, Bioorganic & Medicinal Chemistry Letters Biological ActivityBiochemistryMedicineNatural SciencesAntiviral Drug Development	2009	26

Page 1